×
模态框（Modal）标题
在这里添加一些文本
Close
Close
Submit
Cancel
Confirm
×
模态框（Modal）标题
在这里添加一些文本
Close
×
Please choose a citation manager
RIS (ProCite, Reference Manager)
BibTeX
Content to export
Citation
Citation and abstract
Export
ISSN 1008-5734
CN 11-4015/R
1999年创刊
主管: 中国科学技术协会
主办: 中华医学会
Toggle navigation
Home
About Journal
Editorial Board
Subscription
Submission
Download
FAQ
Conference
中文
Hot Article
More...
WeChat
Most Read
More...
Most Download
More...
Office
Online Submission
Manuscript Tracking
Editor Work
Office Work
Editor-in-Chief
Journal
Earlier Issues
Current Isue
Advanced Search
Browse by Column
Archive
Most Read
Most Download
Email Alert
RSS
Download
More...
Link
More...
Current Issue
Archive
2025,Vol. 27 No. 12 Published: 28 December 2025
Global development of surgical pharmacy: model exploration and discipline construction
Zheng Zhihua, Wang Yong
2025, 27(12): 705-708.
https://doi.org/10.3760/cma.j.cn114015-20250108-00018
Abstract (
)
PDF
(
)
Effect of clinical pharmacist intervention on the efficiency and safety of tranexamic acid in total hip arthroplasty: a case-control study
Wu Huiyi, Zheng Ping, Xu Yaowen, Zhao Yinping, Li Yilei
2025, 27(12): 709-714.
https://doi.org/10.3760/cma.j.cn114015-20250311-00131
Abstract (
)
PDF
(
)
Practice of the management for de-labeling of beta-lactam antibiotics allergies during perioperative period led by clinical pharmacists
Wei Xue, Pan Ying, Li Xiaoyan, Liu Tao
2025, 27(12): 715-719.
https://doi.org/10.3760/cma.j.cn114015-20250327-00167
Abstract (
)
PDF
(
)
Supplementary files
Prediction of tacrolimus exposure and optimization of dosing regimen in patients with liver cirrhosis based on physiologically based pharmacokinetic model
Liu Jing, Yang Dan, Xu Jianwen, Zhou Shuifang, Zhang Desheng, Zhang Shoutian, Guo Guimu
2025, 27(12): 720-727.
https://doi.org/10.3760/cma.j.cn114015-20250429-00234
Abstract (
)
PDF
(
)
Risk signal mining of adverse events related to antibody-drug conjugates trastuzumab deruxtecan and trastuzumab emtansine: a study based on the US Food and Drug Administration Adverse Event Reporting System database
Tian Chunyu, Yang Shaojie, Fu Xian, Zhang Yanhua, Ma Xu, Zhao Bingqing
2025, 27(12): 728-734.
https://doi.org/10.3760/cma.j.cn114015-20241104-00128
Abstract (
)
PDF
(
)
Application status of artificial intelligence technology in adverse drug event prediction and model performance evaluation: a systematic literature analysis
Jiang Yongxian, Zhao Shan, Li Zhangyue, Li Gen, Qin Bo, Yi Zhanmiao
2025, 27(12): 735-744.
https://doi.org/10.3760/cma.j.cn114015-20241211-00200
Abstract (
)
PDF
(
)
Re-evaluation of the severity of adverse drug reactions based on the Common Terminology Criteria for Adverse Events
Jing Shen′ao, Ma Rongrong, Zhang Rui, Liu Fengqin, Zhao Xia, Ma Qingkun, Huang Xin
2025, 27(12): 745-751.
https://doi.org/10.3760/cma.j.cn114015-20250312-00136
Abstract (
)
PDF
(
)
Research progress on practical strategies for penicillin allergy de-labeling
Li Mingfei, Qu Jinghan, Zhang Bo
2025, 27(12): 752-757.
https://doi.org/10.3760/cma.j.cn114015-20250210-00063
Abstract (
)
PDF
(
)
Mitigation of cyclosporine A-induced nephrotoxicity following combination use of empagliflozin and nifedipine
Tian Shengjie, Liu Dingsheng, Yang Yanping
2025, 27(12): 758-761.
https://doi.org/10.3760/cma.j.cn114015-20250115-00033
Abstract (
)
PDF
(
)
Immune-related myocarditis complicated by myositis and myasthenia gravis induced by pembrolizumab
Yang Yuping, Sun Bao, Luo Zhiying, Zhang Bikui, Liu Wenhui
2025, 27(12): 762-765.
https://doi.org/10.3760/cma.j.cn114015-20241105-00131
Abstract (
)
PDF
(
)
Immune-related acute kidney injury caused by camrelizumab
Dai Ying, Qiu Shunru, Cheng Xiangcun, Liang Yu, Xu Wen, Wu Zihao, Wang Yichun
2025, 27(12): 765-768.
https://doi.org/10.3760/cma.j.cn114015‐20241203‐00180
Abstract (
)
PDF
(
)
